Recognizing pulmonary complications in patients with systemic sclerosis

Keyphrases

• Systemic Sclerosis 100%
• Pulmonary Complications 100%
• Pulmonary Arterial Hypertension 66%
• Oral Nifedipine 33%
• Exercise Tolerance 33%
• Calcium Channel Blockers 33%
• Corticosteroids 33%
• Interstitial Lung Disease 33%
• Vasoreactivity 33%
• Cyclophosphamide 33%
• Dyspnea on Exertion 33%
• Reticulonodular 33%
• Acute Dyspnea 33%
• Slow Release 33%
• High-resolution CT 33%
• Dry Cough 33%
• CT Findings 33%
• Exercise Hemodynamics 33%
• Bosentan 33%
• Typical Symptoms 33%
• Epoprostenol 33%
• Basilar 33%
• Oral Calcium 33%

Medicine and Dentistry

• Systemic Scleroderma 100%
• Pulmonary Hypertension 66%
• Symptom 66%
• Interstitial Lung Disease 33%
• Dyspnea 33%
• Honeycombing 33%
• Cyclophosphamide 33%
• Exercise Tolerance 33%
• Exercise 33%
• Bosentan 33%
• Nifedipine 33%
• Prostacyclin 33%
• Hemodynamic 33%
• Azathioprine 33%
• Coughing 33%
• Calcium Channel Blocking Agent 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Systemic Sclerosis 100%
• Pulmonary Hypertension 66%
• Symptom 66%
• Nifedipine 33%
• Cyclophosphamide 33%
• Interstitial Lung Disease 33%
• Dyspnea 33%
• Calcium Channel Blocker 33%
• Prostacyclin 33%
• Azathioprine 33%
• Bosentan 33%
• Coughing 33%